The Volagidemab Biosimilar Anti-GCGR Antibody is a cutting-edge biotherapeutic agent designed for research and potential therapeutic applications involving the glucagon receptor (GCGR). This monoclonal antibody, developed through advanced biotechnology methods, exhibits high specificity and affinity for the GCGR protein, making it an invaluable tool for studying the role of glucagon signaling in metabolic regulation and metabolic disorders.The GCGR, a key player in glucose homeostasis and energy metabolism, is a promising target for the treatment of diabetes and related metabolic conditions. The Volagidemab Biosimilar Anti-GCGR Antibody offers researchers a powerful tool for investigating the molecular mechanisms underlying GCGR signaling and exploring novel therapeutic strategies for managing metabolic diseases.
With its exceptional purity and potency, this biosimilar antibody provides reliable and reproducible results in various experimental assays, including in vitro studies and preclinical research. Its versatility and reliability make it an essential reagent for scientists and clinicians working in the fields of endocrinology, metabolism, and drug development.Overall, the Volagidemab Biosimilar Anti-GCGR Antibody represents a breakthrough in the study of glucagon signaling and holds great promise for advancing our understanding of metabolic disorders and the development of targeted therapies for improving patient outcomes.
Product Name:
Volagidemab (Anti-GCGR) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0124
Target:
GCGR
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AMG 477, REMD-477
Description:
Anti-GCGR(volagidemab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
